___

• Kaynaklar 1.Pinhas-Hamiel O, Zeitler P. The global spread of type 2 diabetes mel-litus in children and adolescents. J Pediatr 2005; 146:693. 2.Weiss R, Caprio S, Trombetta M, et al. Beta-cell function across thespectrum of glucose tolerance in obese youth. Diabetes 2005; 54:1735. 3.Elder DA, Hornung LN, Herbers PM, et al. Rapid deterioration ofinsulin secretion in obese adolescents preceding the onset of type 2diabetes. J Pediatr 2015; 166:672. 4.Dabelea D, Mayer-Davis EJ, Saydah S, et al. Prevalence of type 1and type 2 diabetes among children and adolescents from 2001 to2009. JAMA 2014; 311:1778. 5.Pinhas-Hamiel O, Dolan LM, Daniels SR, et al. Increased inciden-ce of non-insulin-dependent diabetes mellitus among adolescents. JPediatr 1996; 128:608. 6.Writing Group for the SEARCH for Diabetes in Youth Study Gro-up, Dabelea D, Bell RA, et al. Incidence of diabetes in youth in theUnited States. JAMA 2007; 297:2716. 7.Urakami T, Kubota S, Nitadori Y, et al. Annual incidence and cli-nical characteristics of type 2 diabetes in children as detected by uri-ne glucose screening in the Tokyo metropolitan area. Diabetes Care2005; 28:1876. 8.Likitmaskul S, Kiattisathavee P, Chaichanwatanakul K, et al. Increa-sing prevalence of type 2 diabetes mellitus in Thai children and ado-lescents associated with increasing prevalence of obesity. J PediatrEndocrinol Metab 2003; 16:71. 9.United States Centers for Disease Control: National Diabetes Sta-tistics Report, 2014. Available at: http://www.cdc.gov/diabetes/pubs/statsreport14.htm (Accessed on July 18, 2014). 10.Saygın Abalı, Enes Çelik, Belma Haliloğlu, Nuray Kırkıç, Serpil Baş,Zeynep Atay, Tülay Güran, Serap Turan, Abdullah Bereket. Çocuk-luk Çağı Diyabetinde Etiyoloji ve Demografik Özellikler: Marma-ra Deneyimi: Ulusal Pediatrik Endokrinoloji Kongresi İstanbul, 2014 11.Babaoglu K, Hatun S, Arslanoglu I, Isguven P, Bas F, Ercan O, Da-rendelile, F, Bundak R, Saka N, Gunoz H, Bereket A, Memioglu N,Neyzi O. Evaluation of glucose intolerance in adolescents relativeto adults with type 2 diabetes mellitus. J Pediatr Endocrinol Metab.2006 19(11):1319-26. 12.Lee JM, Okumura MJ, Freed GL, et al. Trends in hospitalizationsfor diabetes among children and young adults: United States, 19932004. Diabetes Care 2007; 30:3035. 13.Liu LL, Lawrence JM, Davis C, et al. Prevalence of overweight andobesity in youth with diabetes in USA: the SEARCH for Diabetes inYouth study. Pediatr Diabetes 2010; 11:4. 14.Copeland KC, Zeitler P, Geffner M, et al. Characteristics of adoles-cents and youth with recent-onset type 2 diabetes: the TODAY co-hort at baseline. J Clin Endocrinol Metab 2011; 96:159. 15.Freedman DS, Srinivasan SR, Burke GL, et al. Relation of body fatdistribution to hyperinsulinemia in children and adolescents: the Bo-galusa Heart Study. Am J Clin Nutr 1987; 46:403. 16.Meigs JB, Cupples LA, Wilson PW. Parental transmission of type 2diabetes: the Framingham Offspring Study. Diabetes 2000; 49:2201. 17.Barnett AH, Eff C, Leslie RD, Pyke DA. Diabetes in identical twins.A study of 200 pairs. Diabetologia 1981; 20:87. 18.Voight BF, Scott LJ, Steinthorsdottir V, et al. .; MAGIC investiga-tors; GIANT Consortium .. Twelve type 2 diabetes susceptibility lociidentified through large-scale association analysis. Nat Genet2010;42:579–589 19.Ball GD, Huang TT, Gower BA, et al. Longitudinal changes in in-sulin sensitivity, insulin secretion, and beta-cell function during pu-berty. J Pediatr 2006; 148:16. 20.Gungor N, Hannon T, Libman I, et al. Type 2 diabetes mellitus in yo-uth: the complete picture to date. Pediatr Clin North Am 2005; 52:1579. 21.C Kurtoğlu S, Hatipoğlu N, Mazıcıoğlu M, Kendirici M, Keskin M,Kondolot M. Insulin resistance in obese children and adolescents:HOMA-IR cut-off levels in the prepubertal and pubertal periods. JClin Res Pediatr Endocrinol.2010;2(3):100-6 22.Forsén T, Eriksson J, Tuomilehto J, et al. The fetal and childho-od growth of persons who develop type 2 diabetes. Ann Intern Med2000; 133:176. 23.Sapru A, Gitelman SE, Bhatia S, et al. Prevalence and characteris-tics of type 2 diabetes mellitus in 9-18 year-old children with dia-betic ketoacidosis. J Pediatr Endocrinol Metab 2005; 18:865. 24.Rewers A, Klingensmith G, Davis C, et al. Presence of diabetic ke-toacidosis at diagnosis of diabetes mellitus in youth: the Search forDiabetes in Youth Study. Pediatrics 2008; 121:e1258. 25.American Diabetes Association. 2. Classification and Diagnosis ofDiabetes. Diabetes Care 2017; 40:S11. 26.Shaw JE, Zimmet PZ, McCarty D, de Courten M. Type 2 diabetesworldwide according to the new classification and criteria. Diabe-tes Care 2000; 23 Suppl 2:B5. 27.International Expert Committee. International Expert Committee re-port on the role of the A1C assay in the diagnosis of diabetes. Dia-betes Care 2009; 32:1327. 28.Kapadia C, Zeitler P, Drugs and Therapeutics Committee of the Pe-diatric Endocrine Society. Hemoglobin A1c measurement for the di-agnosis of Type 2 diabetes in children. Int J Pediatr Endocrinol 2012;2012:31. 29.Dabelea D, Pihoker C, Talton JW, et al. Etiological approach to cha-racterization of diabetes type: the SEARCH for Diabetes in YouthStudy. Diabetes Care 2011; 34:1628. 30.Klingensmith GJ, Pyle L, Arslanian S, et al. The presence of GADand IA-2 antibodies in youth with a type 2 diabetes phenotype: re-sults from the TODAY study. Diabetes Care 2010; 33:1970. 31.American Diabetes Association. 5. Prevention or Delay of Type 2 Dia-betes. Diabetes Care 2017; 40:S44. 32.Libman IM, Barinas-Mitchell E, Bartucci A, et al. Reproducibilityof the oral glucose tolerance test in overweight children. J Clin En-docrinol Metab 2008; 93:4231. 33.Quinn SM, Baur LA, Garnett SP, Cowell CT. Treatment of clini-cal insulin resistance in children: a systematic review. Obes Rev2010; 11:722. 34.Willi SM, Martin K, Datko FM, Brant BP. Treatment of type 2 dia-betes in childhood using a very-low-calorie diet. Diabetes Care 2004;27:348. 35.Copeland KC, Silverstein J, Moore KR, et al. Management of newlydiagnosed type 2 Diabetes Mellitus (T2DM) in children and adoles-cents. Pediatrics 2013; 131:364. 36.Springer SC, Silverstein J, Copeland K, et al. Management of type2 diabetes mellitus in children and adolescents. Pediatrics 2013;131:e648. 37.TODAY Study Group, Zeitler P, Epstein L, et al. Treatment optionsfor type 2 diabetes in adolescents and youth: a study of the compa-rative efficacy of metformin alone or in combination with rosiglita-zone or lifestyle intervention in adolescents with type 2 diabetes. Pe-diatr Diabetes 2007; 8:74. 38.TODAY Study Group, Zeitler P, Hirst K, et al. A clinical trial to ma-intain glycemic control in youth with type 2 diabetes. N Engl J Med2012; 366:2247. 39.Kelly AS, Rudser KD, Nathan BM, et al. The effect of glucagon-likepeptide-1 receptor agonist therapy on body mass index in adolescentswith severe obesity: a randomized, placebo-controlled, clinical tri-al. JAMA Pediatr 2013; 167:355. 40.Zinman B, Wanner C, Lachin JM, et al. Empagliflozin, Cardiovas-cular Outcomes, and Mortality in Type 2 Diabetes. N Engl J Med2015; 373:2117. 41.Hasan FM, Alsahli M, Gerich JE. SGLT2 inhibitors in the treatmentof type 2 diabetes. Diabetes Res Clin Pract 2014; 104:297. 42.Tahrani AA, Barnett AH, Bailey CJ. SGLT inhibitors in managementof diabetes. Lancet Diabetes Endocrinol 2013; 1:140. 43.Inge TH, Miyano G, Bean J, et al. Reversal of type 2 diabetes mel-litus and improvements in cardiovascular risk factors after surgicalweight loss in adolescents. Pediatrics 2009; 123:214. 44.Expert Panel on Blood Cholesterol Levels in Children and Adolescents:Treatment recommendations of the National Cholesterol EducationProgram report of the Expert Panel on Blood Cholesterol Levels inChildren and Adolescents. Pediatrics, 1992;89 (Suppl.):525-584. 45.HEALTHY Study Group, Foster GD, Linder B, et al. A school-ba-sed intervention for diabetes risk reduction. N Engl J Med 2010;363:443. 46.Young TK, Martens PJ, Taback SP, Sellers EA, Dean HJ, CheangM, Flett B. Type 2 diabetes mellitus in children: prenatal and earlyinfancy risk factors among native Canadians. Arch Pediatr AdolescMed 2002;156(7):651-5.